| 7.19 Data as of Jun 18 | +0.72 / +11.13%Today’s Change | 1.82 Today|||52-Week Range 7.30 | +97.53% Year-to-Date |
The 3 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 8.00. The median estimate represents a +80.81% increase from the last price of 7.19.

The current consensus among 3 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since June, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




